Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6*1 and CYP2D6*10 using cell-based models in vitro

被引：0
|
作者：
Qiang Qu
Jian Qu
Lu Han
Min Zhan
Lan-xiang Wu
Yi-wen Zhang
Wei Zhang
Hong-hao Zhou
机构：
[1] Institute of Clinical Pharmacology,
[2] Hunan Key Laboratory of Pharmacogenetics,undefined
[3] Xiangya Hospital,undefined
[4] Central South University,undefined
[5] Xiangya Hospital,undefined
[6] Central South University,undefined
[7] Institute of Life Sciences,undefined
[8] Chongqing Medical University,undefined
来源：
Acta Pharmacologica Sinica | 2014年 / 35卷
关键词：
CYP2D6; drug interaction; herbal medicine; coptisine; bilobalide; schizandrin; luteolin; puerarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：685 / 696
页数：11
相关论文
共 50 条
  • [31] CYP2D6 Phenotyping Using Urine, Plasma, and Saliva Metabolic Ratios to Assess the Impact of CYP2D6*10 on Interindividual Variation in a Chinese Population
    Chen, Rui
    Zheng, Xin
    Hu, Pei
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [32] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation:: a study of mutations CYP2D6*3 and CYP2D6*4
    Monek, O
    Paintaud, G
    Bechtel, Y
    Miguet, JP
    Mantion, G
    Bechtel, PR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (01) : 47 - 52
  • [33] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation: a study of mutations CYP2D6*3 and CYP2D6*4
    O. Monek
    G. Paintaud
    Y. Bechtel
    J. P. Miguet
    G. Mantion
    P. R. Bechtel
    European Journal of Clinical Pharmacology, 1998, 54 : 47 - 52
  • [34] CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene
    Skierka, Jennifer M.
    Walker, Denise L.
    Peterson, Sandra E.
    O'Kane, Dennis J.
    Black, John Logan, III
    PHARMACOGENOMICS, 2012, 13 (08) : 951 - 954
  • [35] Metabolic activation of zolmitriptan mediated by CYP2D6
    Han, Lingling
    Jia, Yudi
    Zhao, Yanjia
    Sun, Chen
    Zhao, Min
    Peng, Ying
    Zheng, Jiang
    XENOBIOTICA, 2021, 51 (11) : 1292 - 1302
  • [36] The Effects of Puerarin on CYP2D6 and CYP1A2 Activities In Vivo
    Zheng, Jiao
    Chen, Bin
    Jiang, Bing
    Zeng, Ling
    Tang, Zhi-Rong
    Fan, Lan
    Zhou, Hong-Hao
    ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (02) : 243 - 246
  • [37] The effects of Puerarin on CYP2D6 and CYP1A2 activities In vivo
    Jiao Zheng
    Bin Chen
    Bing Jiang
    Ling Zeng
    Zhi-Rong Tang
    Lan Fan
    Hong-Hao Zhou
    Archives of Pharmacal Research, 2010, 33 : 243 - 246
  • [38] Venlafaxine oxidation in vitro is catalysed by CYP2D6
    Otton, SV
    Ball, SE
    Cheung, SW
    Inaba, T
    Rudolph, RL
    Sellers, EM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (02) : 149 - 156
  • [39] Induction of CYP2D6 in pregnancy
    Wadelius, M
    Darj, E
    Frenne, G
    Rane, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (04) : 400 - 407
  • [40] The interaction of terfenadine with CYP2D6
    Jones, BC
    Hyland, R
    Ackland, M
    Tyman, CA
    Smith, DA
    FASEB JOURNAL, 2000, 14 (08): : A1503 - A1503
12345